Pyrimidine synthesis by intracellular Toxoplasma gondii.
Pyrimidine biosynthesis was studied in actively dividing, intracellular Toxoplasma gondii, in mutant Chinese hamster ovary cells blocked in pyrimidine biosynthesis to eliminate any contribution by the host cell. The parasite grew normally in these cells even though pyrimidines were not supplied in the medium. Uninfected, mutant cultures showed negligible pyrimidine synthesis. However, mutant cultures infected wit T. gondii efficiently incorporated 14C from glucose or aspartic acid into the pyrimidine bases of nucleic acids. Thus T. gondii is capable of de novo pyrimidine biosynthesis. The parasite may also be able to use pyrimidines of the host cell, because of pyrazofurin, an antimetabolite that blocks pyrimidine biosynthesis, markedly inhibited only a mutant parasite defective in the salvage of pyrimidines.
D000577:Amides; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002460:Cell Line; D006224:Cricetinae; D003596:Cytosine / Q000096:biosynthesis; D005947:Glucose / Q000378:metabolism; D006801:Humans; D011720:Pyrazoles; D011743:Pyrimidines / Q000096:biosynthesis*; D012263:Ribonucleosides / Q000494:pharmacology; D012266:Ribose; D013941:Thymine / Q000096:biosynthesis; D014122:Toxoplasma / Q000254:growth & development / Q000378:metabolism*; D014498:Uracil / Q000096:biosynthesis
D000577:Amides; D011720:Pyrazoles; D011743:Pyrimidines; D012263:Ribonucleosides; D001224:Aspartic Acid; C002997:pyrazofurin; D014498:Uracil; D012266:Ribose; D003596:Cytosine; D005947:Glucose; D013941:Thymine